Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Alterity Therapeutics Ltd.
(PRNAF)
OTHER OTC
:PRNAF
PRNAF
Alterity Therapeutics
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Alterity Therapeutics (PRNAF) Stock News & Sentiment
Follow
6
Followers
Premium
Company Announcements
Alterity Investors Approve Resolutions, Clearing Path Toward Pivotal MSA Trial
2d ago
Premium
Company Announcements
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
24d ago
Premium
Company Announcements
Alterity advances ATH434 toward Phase 3 in Multiple System Atrophy after FDA backing
1M ago
Premium
Company Announcements
Alterity Therapeutics Sets Virtual General Meeting for May 29, 2026
1M ago
Premium
Company Announcements
Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy
1M ago
Premium
Company Announcements
Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale
1M ago
Premium
Company Announcements
Alterity Therapeutics Names Ann Cunningham to Board With No Initial Shareholding
1M ago
More PRNAF News >
PRNAF News on the Web
All News
Bearish News
Bullish News
2026-05-29
Alterity Investors Approve Resolutions, Clearing Path Toward Pivotal MSA Trial
TipRanks News
Bullish
2026-05-24
Lunch Wrap: Goldies run hot as Charter Hall keeps the money train rolling
StockHead
Neutral
2026-05-24
Alterity in spotlight at medical conferences as MSA clinical research moves toward Phase III planning
StockHead
Bullish
2026-05-19
Health Check: On International Clinical Trials Day, ASX drug developers are delivering the goods
StockHead
Bullish
2026-05-12
ASX healthcare names putting their science under the spotlight
StockHead
Bullish
2026-05-11
Alterity strengthens ATH434 case with validated brain imaging biomarker in MSA
StockHead
Bullish
2026-05-11
Alterity Therapeutics publishes quantitative susceptibility mapping MRI data
TipRanks News
Neutral
2026-05-06
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
TipRanks News
Bullish
150
Results | Showing
1
out of
19
News Score - Last 7 Days
Very Positive
PRNAF
Sector Average
Media Buzz
This Week
1 articles
Weekly Average
2.75 articles
News Sentiment
This Week
100%
Sector Average
82%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is PRNAF’s Media Buzz Sentiment?
1 articles about PRNAF were published this week. In an average week, 2.75 articles are published.
What is PRNAF’s weekly average amount of articles?
In an average week, 2.75 articles about PRNAF are published.
What is PRNAF’s News Sentiment?
100% of articles about PRNAF were positive this week, compared to its sector average of 82%.
Healthcare Stocks that are Trending in the News
A
Agilent
PHR
Phreesia
ADO
AnteoTech Ltd
OTLK
Outlook Therapeutics
IHHHF
IHH Healthcare Bhd
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.